Намеренное самоповреждающее поведение при пограничном личностном расстройстве. Часть III: диагноз и лечение

Намеренное самоповреждающее поведение при пограничном личностном расстройстве. Часть III: диагноз и лечение

Автор: Любов Евгений Борисович, Зотов Павел Борисович

Журнал: Суицидология @suicidology

Статья в выпуске: 1 (54) т.15, 2024 года.

Бесплатный доступ

Обзор литературы основан на поиске по ключевым словам «пограничное расстройство личности» (ПРЛ), «несуицидальное самоповреждение» и «суицидальное поведение» в MEDLINE и PsycINFO статей с 2000 года. В третьей и заключительной части основное внимание уделено процессу диагностики, объективизации медико-социального бремени и выбору доказательно эффективного комплексного лечения больных ПРЛ как важного ресурсосберегающего и антисуицидального средства.

Пограничное личностное расстройство, диагноз, лечение

Короткий адрес: https://sciup.org/140304507

IDR: 140304507   |   DOI: 10.32878/suiciderus.24-15-01(54)-53-82

Список литературы Намеренное самоповреждающее поведение при пограничном личностном расстройстве. Часть III: диагноз и лечение

  • Beghi M., Negrini P.B., Perin C., et al. Psychogenic non-epileptic seizures: so-called psychiatric co-morbidity and underlying defence mechanisms. Neuropsychiatr. Dis. Treat. 2015; 30: 2519-27. DOI: 10.2147/NDT.S82079
  • Grilo C.M., McGlashan T.H., Morey L.C., et al. Internal consistency, intercriterion overlap and diagnostic efficien-cy of criteria sets for DSM-IV schizotypal, borderline, avoidant and obsessive-compulsive personality disorders. Acta Psychiatr. Scand. 2001; 104 (4): 264-272. DOI: 10.1034/j.1600-0447.2001.00436.x
  • Frías Á., Palma C., Farriols N., González L. Sexuality-related issues in borderline personality disorder: A com-prehensive review. Personal Ment Health. 2016; 10 (3): 216-231. DOI: 10.1002/pmh.1330
  • Zanarini M.C., Frankenburg F.R., Fitzmaurice G. Defense mechanisms reported by patients with borderline personal-ity disorder and axis II comparison subjects over 16 years of prospective follow-up: description and prediction of re-covery. Am. J. Psychiatry. 2013; 170 (1): 111-120. DOI: 10.1176/appi.ajp.2012.12020173
  • Schlapobersky J. From the Couch to the Circle: Group-Analytic Psychotherapy in Practice. Routledge, 2016. 6. Colli A., Tanzilli A., Dimaggio G., Lingiardi V. Patient personality and therapist response: an empirical investiga-tion. Am. J. Psychiatry. 2014;171(1):102-8. DOI: 10.1176/appi.ajp.2013.13020224
  • Pearse L.J., Dibben C., Ziauddeen H., et al. A study of psychotic symptoms in borderline personality disorder. J. Nerv. Ment. Dis. 2014; 202 (5): 368-371. DOI: 10.1097/NMD
  • Merrett Z., Rossell S.L., Castle D.J. Comparing the expe-rience of voices in borderline personality disorder with the experience of voices in a psychotic disorder: A systematic review. Aust. NZ J. Psychiatry. 2016; 50 (7): 640-648. DOI: 10.1177/0004867416632595
  • Porter C., Palmier-Claus J., Branitsky A., et al. Childhood adversity and borderline personality disorder: a meta-analysis. Acta Psychiatr. Scand. 2020; 141 (1): 6-20. DOI: 10.1111/acps.13118
  • Bowlby J. A secure base. NY: Basic Books, 1988.
  • Carcone D., Tokarz V.L., Ruocco A.C. A systematic re-view on the reliability and validity of semistructured diag-nostic interviews for borderline personality disorder. Can. Psychology / Psychologie сanadienne. 2015; 56 (2): 208-226. DOI: 10.1037/cap0000026
  • Суицидальные и несуицидальные самоповреждения подростков / Коллективная монография. Под редакцией проф. П.Б. Зотова. Тюмень: Вектор Бук, 2021. 472 с. ISBN 978-5-91409-537-3
  • Ласовская Т.Ю., Короленко Ц.П., Сарычева Ю.В., Яичников С.В. Распространенность, диагностика и клиника пограничного расстройства личности: НГМУ. Новосибирск: ООО "Печатный дом Новосибирск", 2013. 157. ISBN 978-5-9554-0029-7
  • National Institute for Health and Clinical Excellence (NICE). Borderline personality disorder: Recognition and management, 2009. https://www.nice.org.uk/guidance/cg78
  • White C.N., Gunderson J.G., Zanarini M.C., Hudson J.I. Family studies of borderline personality disorder: a re-view. Harv. Rev. Psychiatry. 2003; 11 (1): 8-19. DOI: 10.1080/10673220303937
  • Harned M.S., Pantalone D.W., Ward-Ciesielski E.F., et al. The prevalence and correlates of sexual risk behaviors and sexually transmitted infections in outpatients with border-line personality disorder. J. Nerv. Ment. Dis. 2011; 199: 832-838. DOI: 10.1097/NMD.0b013e318234c02c
  • De Genna N.M., Feske U., Larkby C., et al. Pregnancies, abortions, and births among women with and without bor-derline personality disorder. Women's Health Issues. 2012; 22 (4): e371-377. DOI: 10.1016/j.whi.2012.05.002
  • Sansone R.A., Chu J.W., Wiederman M.W. Sexual behav-iour and borderline personality disorder among female psychiatric inpatients. Int J Psychiatry Clin Pract. 2011; 15 (1): 69-73. DOI: 10.3109/13651501.2010.507871
  • Senberg A., Schmucker M., Oster A., Zumbach J. Parental personality disorder and child maltreatment: A systematic review and meta-analysis. Child Abuse Negl. 2023; 140: 106148. DOI: 10.1016/j.chiabu.2023.106148
  • Petfield L., Startup H., Droscher H., et al. Parenting in mothers with borderline personality disorder and impact on child outcomes. Evid. Based Ment. Health. 2015; 18 (3): 67-75. DOI: 10.1136/eb-2015-102163
  • Sansone R.A., Sansone L.A. Borderline personality and externalized aggression. Innov. Clin. Neurosci. 2012; 9 (3): 23-26. PMID: 22567607
  • Yu R., Geddes J.R., Fazel S. Personality disorders, violence, and antisocial behavior: a systematic review and meta-regression analysis. J. Pers. Disord. 2012; 26 (5): 775-792. DOI: 10.1521/pedi.2012.26.5.775
  • Hayward M., Slade M., Moran P.A. Personality disorders and unmet needs among psychiatric inpatients. Psychiatr. Serv. 2006; 57: 538-543. DOI: 10.1176/ps.2006.57.4.538
  • Kjær J.N., Biskin R., Vestergaard C., et al. All-cause mor-tality of hospital-treated borderline personality disorder: a nationwide cohort study. J. Personal. Dis. 2020; 34 (6): 723-735. DOI: 10.1521/pedi_2018_32_403
  • Monk-Cunliffe J., Borschmann R., Monk A., et al. Crisis interventions for adults with borderline personality disor-der. Cochrane Database Syst Rev. 2022; 9 (9): CD009353. DOI: 10.1002/14651858.CD009353.pub3
  • Sansone R.A. Chronic suicidality and borderline person-ality. J. Personal. Dis. 2004; 18 (3): 215-225. DOI: 10.1521/pedi.18.3.215.35444
  • National Collaborating Centre for Mental Health. Border-line Personality Disorder: Treatment and Management. Leicester (UK): British Psychological Society, 2009. URL: www.nice.org.uk/guidance/cg78/evidence/bpd-full-guideline-242147197
  • Hastrup L.H., Jennum P., Ibsen R., et al. Societal costs of borderline personality disorders: a matched-controlled na-tionwide study of patients and spouses. Acta Psychiatr. Scand. 2019; 140 (5): 458-467. DOI: 10.1111/acps.13094
  • Bagge C., Nickell A., Stepp S., et al. Borderline personali-ty disorder features predict negative outcomes 2 years later. J. Abnorm. Psychol. 2004; 113 (2): 279-288. DOI: 10.1037/0021-843X.113.2.279
  • Bateman A., Fonagy P. A randomized controlled trial of a mentalization-based intervention (MBT-FACTS) for fami-lies of people with borderline personality disorder. Per-sonal. Dis.: Theory, Res., Treatment. 2019; 10 (1): 70-79. DOI: 10.1037/per0000298
  • Lequesne E.R., Hersh R.G. Disclosure of a diagnosis of borderline personality disorder. J. Psychiatr. Pract. 2004; 10 (3): 170-176. DOI: 10.1097/00131746-200405000-00005
  • Gartlehner G., Crotty K., KennedyS., et al. Pharmacologi-cal treatments for borderline personality disorder: a sys-tematic review and meta-analysis. CNS Drugs. 2021; 35: 1053-1067. DOI: 10.1007/s40263-021-00855-4
  • Stoffers-Winterling J.M., Storebø O.J., Pereira Ribeiro J., et al. Pharmacological interventions for people with bor-derline personality disorder. Cochrane Database Syst Rev. 2022; 2022: 12956. DOI: 10.1002/14651858.CD012956
  • Simonsen S., Bateman A., Bohus М., et al. European guidelines for personality disorders: past, present and fu-ture. Borderline Pers. Disord. Emot. Dysregulat. 2019; 6:9. DOI: 10.1186/s40479-019-0106-3
  • Bozzatello P., Rocca P., De Rosa M.L., Bellino S. Current and emerging medications for borderline personality dis-order: is pharmacotherapy alone enough? Expert Opin. Pharmacother. 2020; 21: 47-61. DOI: 10.1080/14656566.2019.1686482
  • Storebø O.J., Stoffers-Winterling J.M., Völlm B.A., et al. Psychological therapies for people with borderline person-ality disorder. Cochrane Database of Systematic Rev. 2020; 5: CD012955. DOI: 10.1002/14651858.CD012955.pub2
  • Linehan M.M., Comtosis K.A., et al. Two-year ran-domized controlled trial and follow-up of dialectical be-haviour therapy vs. therapy by experts for suicidal behav-iours and borderline personality disorder. Arch. Gen. Psy-chiatry. 2006; 63 (7): 757-766. DOI: 10.1001/archpsyc.63.7.757
  • Kealy D., Ogrodniczuk J.S. Marginalization of borderline personality disorder. J. Psychiatr. Pract. 2010; 16 (3): 145-154. DOI: 10.1097/01.pra.0000375710.39713.4d.
  • Maconick L., Ikhtabi S., Broeckelmann E., et al. Crisis and acute mental health care for people who have been given a diagnosis of a 'personality disorder': a systematic review. BMC Psychiatry. 2023; 23 (1): 720. DOI: 10.1186/s12888-023-05119-7
  • Stapleton A., Wright N. The experiences of people with borderline personality disorder admitted to acute psychiat-ric inpatient wards: a meta-synthesis. J. Ment. Health. 2019; 28 (4): 443-457. DOI: 10.1080/09638237.2017.1340594
  • Forte A., Buscajoni A., Fiorillo A., et al. Suicidal Risk Following Hospital Discharge: A Review. Harv. Rev. Psy-chiatry. 2019; 27 (4): 209-216. DOI: 10.1097/HRP.0000000000000222
  • Qin P., Nordentoft M. Suicide risk in relation to psychiat-ric hospitalization: evidence based on longitudinal regis-ters. Arch. Gen. Psychiatry. 2005; 62 (4): 427-432. DOI: 10.1001/archpsyc.62.4.427
  • Национальное руководство по суицидологии. Под ред. Б.С. Положего. Москва: МИА, 2019. [The National Guide to Suicidology. Edited by B.S. Polozhego. Moscow: MIA, 2019.] (In Russ)
  • Warrender D., Bain H., Murray I., Kennedy C. Perspec-tives of crisis intervention for people diagnosed with "borderline personality disorder": an integrative review. J. Psychiatric Mental Health Nurs. 2021; 28 (2): 208-236. DOI: 10.1111/jpm.12637
  • Witt K.G., Hetrick S.E., Rajaram G., et al. Psychosocial interventions for self-harm in adults. Cochrane Database of Systematic Rev. 2021; 4. Art: CD013668. DOI: 10.1002/14651858.CD013668.pub2
  • Wood L., Newlove L. Crisis-focused psychosocial inter-ventions for borderline personality disorder: systematic review and narrative synthesis. BJPsych Open. 2022; 8 (3): e94. DOI: 10.1192/bjo.2022.54
  • Bohus M., Stoffers-Winterling J., Sharp C., et al. Border-line personality disorder. Lancet. 2021; 398 (10310): 1528-1540. DOI: 10.1016/S0140-6736(21)00476-1
  • Paris J. Suicidality in Borderline Personality Disorder. Medicina (Kaunas). 2019; 55 (6): 223. DOI: 10.3390/medicina55060223.
  • Lequin P., Ferrari P., Suter C., et al. The Joint Crisis Plan: A Powerful Tool to Promote Mental Health. Front Psy-chiatry. 2021; 12: 621436. DOI: 10.3389/fpsyt.2021.621436
  • Rebok F., Teti G.L., Fantini A.P., et al. Types of border-line personality disorder (BPD) in patients admitted for su-icide-related behavior. Psychiatr Q. 2015; 86 (1): 49-60. DOI: 10.1007/s11126-014-9317-3
  • DeLeo K., Maconick L., McCabe R., et al. Experiences of crisis care among service users with complex emotional needs or a diagnosis of “personality disorder”, and other stakeholders: systematic review and meta-synthesis of the qualitative literature. Bjpsych. Open. 2022; 8 (2): 53. DOI: 10.1192/bjo.2022.1
  • American Psychiatric Association Practice Guidelines. Practice guideline for the treatment of patients with bor-derline personality disorder. American Psychiatric Associ-ation. Am. J. Psychiatry. 2001; 158 (10 Suppl): 1-52. PMID: 11665545
  • Bozzatello P., Rocca P., De Rosa M.L., Bellino S. Current and emerging medications for borderline personality dis-order: is pharmacotherapy alone enough? Expert Opin. Pharmacother. 2020; 21: 47- 61. DOI: 10.1080/14656566.2019.1686482
  • Lunghi C., Cailhol L., Massamba V., et al. Psychotropic medication use pre and post-diagnosis of cluster B person-ality disorder: a Quebec’s health services register cohort. Front. Psychiatry. 2023; 14: 1243511. DOI: 10.3389/fpsyt.2023.1243511
  • Heikkinen M., Taipale H., Tanskanen A., et al. Associa-tion of Pharmacological Treatments and Hospitalization and death in individuals with amphetamine use disorders in a Swedish Nationwide cohort of 13 965 patients. JAMA Psychiatry. 2023; 80: 31-39. DOI: 10.1001/jamapsychiatry.2022.3788
  • Lieslehto J., Tiihonen J., Lähteenvuo M., et al. Associa-tion of pharmacological treatments and real-world out-comes in borderline personality disorder. Acta Psychiatr. Scand. 2023; 147: 603-613. DOI: 10.1111/acps.13564
  • Cortese S., Adamo N., del Giovane C., et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet. Psychiatry. 2018; 5: 727-738. DOI: 10.1016/S2215-0366(18)30269-4
  • Treagust N., Sidhom E., Lewis J., et al. The epidemiology and clinical features of personality disorders in later life; a study of secondary care data. Int. J. Geriatr. Psychiatry. 2022; 37. DOI: 10.1002/gps.5837
  • Davies L.E., Spiers G., Kingston A., et al. Adverse out-comes of polypharmacy in older people: systematic review of reviews. J. Am. Med. Dir. Assoc. 2020; 21: 181-187. DOI: 10.1016/j.jamda.2019.10.022
  • Li Y., Zhang X., Yang L., et al. Association between polypharmacy and mortality in the older adults: a system-atic review and meta-analysis. Arch. Gerontol. Geriatr. 2022; 100: 104630. DOI: 10.1016/j.archger.2022.104630
  • Wong N.Z.Y., Barnett P., Rains L.S., et al. Evaluation of international guidance for the community treatment of ‘personality disorders’: a systematic review. PLoS One. 2023; 18: e0264239. DOI: 10.1371/journal.pone.0264239
  • Lieslehto J., Tiihonen J., Lähteenvuo M., et al. Associa-tion of pharmacological treatments and real-world out-comes in borderline personality disorder. Acta Psychiatr. Scand. 2023; 147: 603-613. DOI: 10.1111/acps.13564
  • 63. Stoffers-Winterling J., Storebø O.J., Lieb K. Pharma-cotherapy for borderline personality disorder: an update of published, unpublished and ongoing studies. Curr. Psy-chiatry Rep. 2020; 22: 37. DOI: 10.1007/s11920-020-01164-1
  • Khalifa N.R., Gibbon S., Völlm B.A., et al. Pharmacologi-cal interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2020; 9: Cd007667. DOI: 10.1002/14651858.CD007667.pub3
  • Excellence NNIfHaC. Borderline personality disorder: recognition and management. Cg78. 2009: 1-40.
  • Linehan M.M. Cognitive-behavioral treatment of border-line personality disorder. NY: Guilford Press; 1993.
  • Friesen L., Gaine G., Klaver E., et al. Key stakeholders' experiences and expectations of the care system for indi-viduals affected by borderline personality disorder: An in-terpretative phenomenological analysis towards co-production of care. PLoS One. 2022; 17 (9): e0274197. DOI: 10.1371/journal.pone.0274197
  • Warrender D., Bain H., Murray I., Kennedy C. Perspec-tives of crisis intervention for people diagnosed with "bor-derline personality disorder": an integrative review. J. Psychiatr. Ment. Health Nurs. 2021; 28 (2): 208-236. DOI: 10.1111/jpm.12637
Еще
Статья обзорная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp